August 28, 2025

First Generic GLP-1 for Weight Loss Approved

FDA approves Teva’s generic Saxenda (liraglutide) with adult and adolescent indications and a boxed thyroid tumor warning.

Conexiant

August 27, 2025

FDA Approves LP.8.1 COVID-19 Vaccines

LP.8.1-targeted COVID-19 vaccines for adults 65 and older and higher-risk patients were approved by the US Food and Drug Administration.

Conexiant

August 25, 2025

What Does Xlear’s Lawsuit Mean for Physicians?

Xlear's xylitol maker sues the FTC to loosen evidence rules on health claims, signaling a deregulatory push that could reshape supplement marketing.

KFF Health News

August 22, 2025

Kinase Inhibitor Approved for Nonsquamous NSCLC With HER2 TKD–Activating Mutations

The agent was approved by the FDA today for adults with unresectable or metastatic nonsquamous NSCLC whose tumors have HER2 tyrosine kinase domain (TKD)–activating mutations, as detected by an FDA-app...

The ASCO Post

August 19, 2025

Bedtime Cyclobenzaprine Relieves Fibromyalgia: Randomized Trial

Researchers found bedtime sublingual cyclobenzaprine reduced pain versus placebo and improved sleep, fatigue, and function with mostly mild oral adverse events.

Conexiant

August 18, 2025

US Vaccine Panels: Conflict and Recusal Trends

Reported conflicts of interest in US vaccine advisory panels have dropped to historically low levels.

Conexiant

August 15, 2025

FDA Approves Non-Opioid Fibromyalgia Therapy

Tonmya reduces fibromyalgia pain versus placebo in phase 3 trials, offering a non-opioid option with a generally well-tolerated safety profile.

Conexiant

August 15, 2025

Approved: HPV-Targeted Immunotherapy for Recurrent Respiratory Papillomatosis

Standard management has relied on repeated surgical debulking, which does not eradicate underlying HPV infection.

Conexiant

August 12, 2025

FDA Approves First Therapy for Non-cystic Fibrosis Bronchiectasis

Brensocatib (Brinsupri) will offer a new treatment option for patients 12 years and older.

Conexiant